Spark Therapeutics CEO Jeff Marrazzo On The Future Of Gene Therapy | CNBC

Spark Therapeutics CEO on breakthroughs in gene therapyПодробнее

Helping The Blind To See Using Gene Therapy | CNBCПодробнее

Spark Therapeutics CEO: Sight For The Blind | Mad Money | CNBCПодробнее

Jeff Marrazzo of Spark Therapeutics Discusses Pricing of His Company's Gene TherapyПодробнее

Jeff Marrazzo from Spark TherapeuticsПодробнее

Jeff Marrazzo of Spark Therapeutics Discusses His CompanyПодробнее

Jeff Marrazzo of Spark Therapeutics Discusses Educating Patients and Physicans about Gene TherapyПодробнее

Spark Therapeutics CEO: Giving Sight To The Blind | Mad Money | CNBCПодробнее

Spark's hemophilia gene therapy reduced bleeds by 97% trialПодробнее

Greater Philadelphia Innovation Showcase, BIO 2019 - Jeffrey Marrazzo, Spark TherapeuticsПодробнее

Cell Therapies & the Future of Biotech | #𝗦𝗔𝗟𝗧𝗡𝗬Подробнее

Buzz Center Interview with Jeff MarrazzoПодробнее

Jeff Marrazzo Discusses How His Company Values and Works with Patient GroupsПодробнее

CNBC Explains: What Is Gene Therapy? | CNBCПодробнее

Spark Therapeutics shares lose nearly a third of their value as hemophilia gene therapy trial disappПодробнее

Sparks! | Bruce Levine | Treating untreatable cancers with gene therapyПодробнее

Jeff Marrazzo Discusses His Company's Hemophilia PortfolioПодробнее

Welcome + Sponsor Remarks // Presented by Spark TherapeuticsПодробнее

Spark Therapeutics | Learn How I Turned $15,253 Into $1,613,442 Trading Biotech StocksПодробнее